Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Multiple mechanisms involved in neuroprotective effects of dexanabinol

May 4, 1998

Efficacy of racemic form of LY-300164 in clonic status epilepticus

May 4, 1998

Chiroscience submits NDA to FDA for Chirocaine

May 4, 1998

Bayer's potassium channel ligands for cognition disorders

May 4, 1998

Pfizer synthesizes dual ORL1 antagonists/opioid receptor agonists

May 4, 1998

First clinical results reported for NPS-1506

May 1, 1998

LY-300164 suppresses kindling-induced seizures in mice

May 1, 1998

Lamotrigine evaluated for the treatment of childhood autism

May 1, 1998

Beneficial effects of tolcapone on sleep disturbances in parkinsonian patients

May 1, 1998

Potent calpain inhibitors disclosed by Mitsubishi Chem.

May 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...